ClinicalTrials.gov
public full text
Public Domain
Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects
The purpose of this pilot study is to determine how the anti-platelet drug, ticagrelor, impacts platelet mRNA splicing after a single loading dose in 10 healthy participants. These results will be valuable in that they will help inform our analysis of platelet RNA splicing after a thrombotic event.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Lovaza's Effect on the Activation of Platelets#994293
- A Prescription Support Tool for Oral Antithrombotic Combinations#843085
- Effects of Platelet-rich Fibrin and Vitamin Dꝫ Injections on the Periodontal Health#1057829
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban#1171610
- The association between RDW-to-platelet ratio and in-hospital mortality in critically ill stroke patients: A retrospective cohort study based on the eICU database.#30614
Record · ID 1137475
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive